Publikation: G-CSF: Boosting endogenous production - a new strategy?
Lade...
Dateien
Datum
2004
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Current Opinion in Investigational Drugs. 2004, 5(11), pp. 1148-1152
Zusammenfassung
Granulocyte colony-stimulating factor (G-CSF) has been in clinical use for over a decade. Its main applications are in adjunctive medication to chemotherapy and in mobilizing stem cells for bone marrow transplantation. However. it has additional effects in that it primes neutrophilic granulocytes for improved host defense, and reduces the release of pro-inflammatory cytokines. These effects have prompted trials for numerous other indications. New research into the production and regulation of G-CSF in health and disease may now enable tailored strategies to induce or boost G-CSF formation. Similarly. new forms of application may increase its effectiveness.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Clinical applications, endogenous production, granulocyte colony-stimulating factor, Lyme borreliosis, sepsis
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
AULOCK, Sonja von, Isabel DITERICH, Lars HARENG, Thomas HARTUNG, 2004. G-CSF: Boosting endogenous production - a new strategy?. In: Current Opinion in Investigational Drugs. 2004, 5(11), pp. 1148-1152BibTex
@article{Aulock2004Boost-8109,
year={2004},
title={G-CSF: Boosting endogenous production - a new strategy?},
number={11},
volume={5},
journal={Current Opinion in Investigational Drugs},
pages={1148--1152},
author={Aulock, Sonja von and Diterich, Isabel and Hareng, Lars and Hartung, Thomas}
}RDF
<rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/8109">
<dc:contributor>Hartung, Thomas</dc:contributor>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8109/1/G_CSF_Boosting_endogenous_production_a_new_strategy.pdf"/>
<dc:rights>terms-of-use</dc:rights>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:40:41Z</dcterms:available>
<dc:creator>Diterich, Isabel</dc:creator>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:issued>2004</dcterms:issued>
<dcterms:bibliographicCitation>First publ. in: Current Opinion in Investigational Drugs 5 (2004), 11, pp. 1148-1152</dcterms:bibliographicCitation>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<dc:creator>Aulock, Sonja von</dc:creator>
<dc:contributor>Hareng, Lars</dc:contributor>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8109"/>
<dcterms:title>G-CSF: Boosting endogenous production - a new strategy?</dcterms:title>
<dc:contributor>Aulock, Sonja von</dc:contributor>
<dcterms:abstract xml:lang="eng">Granulocyte colony-stimulating factor (G-CSF) has been in clinical use for over a decade. Its main applications are in adjunctive medication to chemotherapy and in mobilizing stem cells for bone marrow transplantation. However. it has additional effects in that it primes neutrophilic granulocytes for improved host defense, and reduces the release of pro-inflammatory cytokines. These effects have prompted trials for numerous other indications. New research into the production and regulation of G-CSF in health and disease may now enable tailored strategies to induce or boost G-CSF formation. Similarly. new forms of application may increase its effectiveness.</dcterms:abstract>
<dc:creator>Hartung, Thomas</dc:creator>
<dc:contributor>Diterich, Isabel</dc:contributor>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8109/1/G_CSF_Boosting_endogenous_production_a_new_strategy.pdf"/>
<dc:language>eng</dc:language>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:40:41Z</dc:date>
<dc:creator>Hareng, Lars</dc:creator>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:format>application/pdf</dc:format>
</rdf:Description>
</rdf:RDF>Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
